Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
DeCaro Auctions unveils a broadened leadership slate as it targets international expansion of its luxury real estate ...
Ethereum sits in a tight range while on-chain tokenized Treasuries on the network surpass $8 billion, marking a major...
A rare signal has emerged as markets hit new highs. This article explains what a stock market flashing warning could ...
Could eBay join the meme stock conversation? This article breaks down what it means for investors, the driver behind ...
AI reshapes entry-level work as automation accelerates, pushing colleges to rethink internships and hands-on experien...
Rate has added Scottsdale, Arizona-based loan originator Kelsey Marquardt to its Chicago-based mortgage platform, sig...
A new executive directive directs the Federal Reserve to reassess whether non-bank fintech and crypto firms can acces...
Berkshire Hathaway has been selling some positions, but a single airline stock remains a headline-grabber. This artic...
What makes a beaten-down stock worth a closer look? This article breaks down the signs, runs a hypothetical comeback ...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...
The CLARITY Act aims to separate crypto oversight between the SEC and CFTC while probing foreign adversary risks. Cri...